250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in Spain in September 2025

A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Spain. We rank investors based on the number of investments they made in Life science companies from Spain. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in Spain in September 2025

Investor Life Science Spain investments
Centre for the Development of Industrial Technology (CDTI) 8
Bullnet Capital 7
Capital Cell 6
ENISA 4
Asabys Partners 4
Invivo Capital Partners 3
Talis Capital 2
Josep Carreras Leukaemia Research Institute 2
Charme Capital Partners 2
Speedinvest 2
Amino Collective 2
Criteria Venture Tech 2
Monte Carlo Capital 2
Alta Life Sciences 2
BoxOne Ventures 2
Nara Capital 2
BStartup 2
Ysios Capital 2
Amadeus Capital Partners 2
Demium Capital 2
Inveready 2
Xesgalicia 2
Good Seed Ventures 1
Nina Capital 1
Gilde Healthcare 1
Green Generation Fund 1
GENESIS Biomed 1
BeAble Capital 1
Ship2B Ventures 1
General Inception 1
Fides Capital 1
Ezten Venture Capital Fund 1
European Investment Bank 1
Banc Sabadell and the Institut Català de Finances (ICF) 1
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA 1
Novartis Venture Fund 1
Reig Jofre 1
Global health sciences venture fund 1
CRB Inverbío 1
Veg Capital 1
Grow Venture Partners 1
mVenturesBCN 1
Catalan Institution for Research and Advanced Studies 1
Clave 1
Grupo Ferrer Internacional 1
Alma Mundi Ventures 1
Innova-Tech Consulting 1
BCN PEPTIDES 1
CDTI 1
Inveniam 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Centre for the Development of Industrial Technology (CDTI) VC Fund · Madrid, Madrid, Spain · 29 investments in the past 12 months
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Seed, Grant
  • Spain, United States, France
Portfolio highlights
  • KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
  • Niche Mobility — Niche developes electric propulsion systems for e-bicycles with integrated digital gearchange.
  • UPTECH SENSING — UPTECH SENSING designs, manufactures, and operates monitoring systems based on fiber optic solutions.
Bullnet Capital VC Fund · Pozuelo De Alarcón, Madrid, Spain · 2 investments in the past 12 months
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more
Investment focus
  • Software, Information Technology, Enterprise Software
  • Funding Round, Seed, Series A
  • Spain, United States, Mexico
Portfolio highlights
  • wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
  • Bioherent — Photonic biosensors for drug allergy diagnosis
  • Inspiration-Q — Inspiration-Q focuses on developing and commercializing software solutions inspired by quantum computing for financial applications.
Capital Cell VC Fund · Barcelona, Catalonia, Spain · 2 investments in the past 12 months
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Equity Crowdfunding, Seed, Funding Round
  • Spain, United States, United Kingdom
Portfolio highlights
  • MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
  • OxyPrem — OxyPrem is a Swiss manufacturer of next-generation medical devices for oxygen-related brain monitoring of preterm infants in real time, using harmless, non-invasive near-infrared light. Our sensors continuously measure local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
  • MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
ENISA VC Fund · Madrid, Madrid, Spain · 10 investments in the past 12 months
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Debt Financing, Pre-Seed
  • Spain, United States, France
Portfolio highlights
  • Mygocu — Mygocu is a platform for selling, organizing, and managing excursions and large-scale events.
  • Supercubo — Supercubo is a Spanish startup based in Seville, founded with the goal of promoting healthy lifestyle habits by facilitating the creation of outdoor functional training centers through a scalable, low-risk, and cost-effective solution.Our project aims to both ease access for entrepreneurs and foster the growth of our community.The company wasfounded in December 2023 (starting operations in March 2024), and to date, the proof-of-concept for our three business lines has already been implemented and validated: • Own gyms • Franchisees • Third-party sales
  • Modular DS — Modular DS enables WordPress professionals and businesses to save time managing their websites.
Asabys Partners VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
  • Biotechnology, Medical Device, Health Care
  • Series A, Seed, Series B
  • Spain, France, Belgium
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
Invivo Capital Partners VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Seed, Funding Round, Series A
  • Spain, France, Belgium
Portfolio highlights
  • Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
  • Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
  • Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Talis Capital VC Fund · London, England, United Kingdom
We back founders who see the future differently.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Acin — Acin delivers at speed by combining unique industry data, AI and high touch expertise. The trusted partner, built by the industry, for the industry
  • Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
  • Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Josep Carreras Leukaemia Research Institute VC Fund · Badalona, Catalonia, Spain
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Spain
Portfolio highlights
Charme Capital Partners VC Fund · Milano, Lombardia, Italy
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more
Investment focus
  • Genetics, Life Science, Biotechnology
  • Series A
  • Spain
Portfolio highlights
  • Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
  • Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Speedinvest VC Fund · Vienna, Wien, Austria · 36 investments in the past 12 months
Speedinvest is one of Europe’s most active early-stage venture capital funds, with more than €1.2bn in AuM and offices in Berlin, London, Munich, Paris, and Vienna. Our dedicated sector-focused teams (Climate Tech & Industrial Tech, Deep Tech, Fintech, Health & Bio, Marketplaces & Consumer Tech, SaaS & Infra) are the first to fundEMEA's most innovative pre-Seed and Seed tech startups. Our in-house operational experts and global network of industry leaders support our portfolio companies with growth, people (HR), market expansion, and more throughout every stage of their journeys. Bitpanda, GoStudent, Wayflyer, Open, CoachHub, Schüttflix, TourRadar, Adverity, and TWAICE are among our portfolio of 400+ companies.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Pre-Seed
  • United Kingdom, Germany, Austria
Portfolio highlights
  • ARX Robotics — ARX is a defence technology company that specialises in developing autonomous unmanned systems and sensors for the European defence sector.
  • Due — Discover our global payment platform. Powered by open, decentralised and interoperable networks.
  • Tibo Energy — To make sure you operate within the limits of your contract we control your network. We avoid congestion in your energy network.
Amino Collective VC Fund · Berlin, Berlin, Germany · 3 investments in the past 12 months
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Pre-Seed, Series A
  • United States, Germany, United Kingdom
Portfolio highlights
  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
  • Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Criteria Venture Tech VC Fund · Barcelona, Catalonia, Spain · 2 investments in the past 12 months
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more
Investment focus
  • Software, Biotechnology, E-Commerce
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • Scalestack — Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline.
  • iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.
Monte Carlo Capital VC Fund · Monaco, Bayern, Germany · 3 investments in the past 12 months
Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).
Show more
Investment focus
  • Medical Device, Financial Services, Medical
  • Seed, Funding Round, Series A
  • United States, United Kingdom, Spain
Portfolio highlights
  • 1849 Bio — 1849 Bio creates microbes for affordable metal extraction from low-grade copper and gold ores.
  • Scout AI — Scout AI is building the robotic foundation model for defense.
  • Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!
Alta Life Sciences VC Fund · Barcelona, Catalonia, Spain
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Series A, Funding Round, Seed
  • Spain, United States
Portfolio highlights
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
BoxOne Ventures VC Fund · Montréal, Quebec, Canada · 7 investments in the past 12 months
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Pre-Seed, Series A
  • Canada, United States, United Kingdom
Portfolio highlights
  • Xatoms — At Xatoms, we clean water with Quantum Chemistry and AI, revolutionizing water purification for communities worldwide. Our innovative approach rapidly identifies new, sustainable materials to remove harmful pollutants and pathogens. We aim to alleviate the burden on women and girls in underrepresented communities, transforming the global landscape of water accessibility and empowering a more equitable world. Xatoms is at the forefront of combining scientific innovation with social change.
  • Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Nara Capital VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more
Investment focus
  • Biotechnology, Life Science, Medical
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
  • Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
  • Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
BStartup VC Fund · Sant Cugat Del Vallès, Catalonia, Spain · 3 investments in the past 12 months
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Funding Round, Pre-Seed
  • Spain, Mexico, United States
Portfolio highlights
  • Kloutit — Kloutit specializes in chargeback management automated AI solutions.
  • Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
  • xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.
Ysios Capital VC Fund · San Sebastian, Pais Vasco, Spain · 5 investments in the past 12 months
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Spain, United States, Switzerland
Portfolio highlights
  • ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Amadeus Capital Partners VC Fund · Cambridge, Cambridgeshire, United Kingdom · 6 investments in the past 12 months
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Series B, Seed, Series A
  • United Kingdom, United States, Spain
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • Inephany — Inephany - We build systems to train AI agents specialised in optimising Neural Networks, such as LLMs and other Generative AI.
  • Safe Intelligence — Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
Demium Capital VC Fund · Valencia, Comunidad Valenciana, Spain · 5 investments in the past 12 months
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • Spain, Portugal, Poland
Portfolio highlights
  • Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
  • Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
  • Aino — Get site analysis in minutes instead of weeks by just asking questions to AI. No coding or GIS skils needed.
Inveready VC Fund · Barcelona, Catalonia, Spain · 7 investments in the past 12 months
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • Spain, United States, United Kingdom
Portfolio highlights
  • Orbidi — Orbidi is a digital marketing agency that provides SEO, website building, and Google Maps integration services for businesses.
  • Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
  • The Channel Store — The Channel Store is a company specializing in the creation, distribution, and monetization of various types of channels, particularly in the FAST (Free Ad-Supported Streaming TV) and AVOD (Ad-Supported Video on Demand) sectors. It operates as a B2B service provider that manages content negotiations, integration, and monetization for its partners,enabling broadcasters, content owners, telcos, and streaming services to access and distribute a wide range of live and on-demand content globally.
Xesgalicia VC Fund · Santiago De Compostela, Galicia, Spain
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more
Investment focus
  • Software, Biotechnology, Pharmaceutical
  • Seed, Funding Round, Pre-Seed
  • Spain, Portugal
Portfolio highlights
  • Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
  • Appentra — Ensure correctness, modernization, security, and optimization for your Fortran, C, and C++ code with a powerful and efficient solution.
  • Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
Good Seed Ventures VC Fund · Rheine, Nordrhein-Westfalen, Germany
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Pre-Seed
  • Germany, Israel, United States
Portfolio highlights
  • Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 8 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Germany
Portfolio highlights
  • CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
  • EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
  • Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Gilde Healthcare VC Fund · Utrecht, Utrecht, The Netherlands · 11 investments in the past 12 months
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, The Netherlands, Germany
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Noema Pharma — BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li ...
  • Alleviant Medical — Interventional therapy for congestive heart failure
Green Generation Fund VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
The Green Generation Fund invests in early stage Food Tech and Green Tech companies that make our lives and diets more sustainable, healthy and ethical.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, United States, Spain
Portfolio highlights
  • Reverion — Reverion offers electrical efficiencies for both power generation and energy storage. Reverion was foun ded in 2022 and was headquartered in Bayern, Germany.
  • smatch — Smatch takes care of stock management and helps retailers to better buy merchandise.
  • Change Foods — We (re)create real dairy foods that delight the taste buds, nourish people and sustain the planet, by using the magic of microbes instead of animals.
GENESIS Biomed VC Fund · Barcelona, Catalonia, Spain · 2 investments in the past 12 months
Life sciences R&D, consulting and investment
Show more
Investment focus
  • Medical, Pharmaceutical, Biopharma
  • Seed, Pre-Seed, Funding Round
  • Spain
Portfolio highlights
  • Thytech — Thytech is a health tech company.
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
  • Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.
BeAble Capital VC Fund · Madrid, Madrid, Spain · 5 investments in the past 12 months
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more
Investment focus
  • Biotechnology, Manufacturing, Product Management
  • Pre-Seed, Seed, Funding Round
  • Spain, Italy
Portfolio highlights
  • Reinforce 3D — Reinforce3D develops proprietary technology for reinforcing 3D-printed parts, called the continuous fiber injection process (CFIP)
  • ALCYON PHOTONICS — ALCYON
  • Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
Ship2B Ventures VC Fund · Barcelona, Catalonia, Spain · 6 investments in the past 12 months
Ship2B Ventures is a venture capital firm that invests in impact startups.
Show more
Investment focus
  • Health Care, Biotechnology, Agriculture
  • Seed, Series A, Funding Round
  • Spain, Germany, United Kingdom
Portfolio highlights
  • Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
  • Nido — Heating & cooling accounts for nearly half of all energy consumption and 40% of energy-related carbon dioxide emissions. In the EU 65M+ boilers are over their useful life and 95% of them use fossil fuels and these need urgent change.At Nido, we are streamlining heat pump installation in the residential sector, enabling users to transition toclean heating & cooling faster with affordable pricing. We also support installers get the best out of their time by removing time consuming tasks and allowing them to focus on their preferred task - home installations!
  • Ocean Ecostructures — We convert maritime infrastructures into 'nature positive' spaces through our multi-technological solution.
General Inception VC Fund · San Francisco, California, United States · 2 investments in the past 12 months
General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception.
Show more
Investment focus
  • Biotechnology, Life Science, Genetics
  • Seed, Pre-Seed
  • United States, Spain, France
Portfolio highlights
  • Biocellis — Biocellis develops ultra-sensitive, bioluminescence-based diagnostics for next-generation immunoassays. Scalable, fast, and point-of-care ready.
  • Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
  • Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
Fides Capital VC Fund · Madrid, Madrid, Spain
Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more
Investment focus
  • Software, Automotive, Telecommunications
  • Seed, Pre-Seed, Series A
  • Spain
Portfolio highlights
  • Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
  • Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
  • CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Ezten Venture Capital Fund VC Fund
Ezten Venture Capital Fund
Show more
Investment focus
  • Software, Automotive, Clean Energy
  • Funding Round, Seed
  • Spain
Portfolio highlights
  • EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
  • Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 45 investments in the past 12 months
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Debt Financing, Post-IPO Debt, Funding Round
  • France, Germany, The Netherlands
Portfolio highlights
  • Solynta — Welcome to the homepage of Solynta, leader in hybrid potato breeding and development of hybrid true potato seeds with attractive traits.
  • Evaxion Biotech — Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currentlyincludes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus) induced skin and soft tissue infections.
  • Electrica — Electrica is a holding company involved in projects connected to the provision of power to final consumers as well as the development and operation of electrical distribution networks. It primarily serves as the principal electricity supplier in and throughout the town as well as an electricity distribution operator. The following segments make upthe company's business: electricity and gas supply, which is involved in acquiring and providing electricity and gas to end users, electricity generation, which produces electricity, electricity distribution, which offers services related to electricity distribution, external electricity network services, which provides maintenance, repairs, and other services for electricity networks owned by other distributors, and electricity distribution.
Banc Sabadell and the Institut Català de Finances (ICF) VC Fund
Banc Sabadell and the Institut Català de Finances (ICF)
Show more
Investment focus
  • Wellness, Health Care, Medical Device
  • Pre-Seed, Series A, Debt Financing
  • Spain
Portfolio highlights
  • Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
  • Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
  • Adan Medical Innovation — Adan Medical is a digital health company that develops integrated solutions for the management of anaphylaxis. Their mission is to improve the quality of life of patients that suffer severe allergic reactions requiring epinephrine.The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays twodifferent products in its pipeline: AnAPPhylaxis, a smart case for epinephrine auto-injectors connected to a mobile App, and WE SAVE, a smart box of epinephrine auto-injectors for public spaces.
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA VC Fund
CDTI
Show more
Investment focus
  • Apps, Big Data, Aerospace
  • Pre-Seed, Series A
  • Spain
Portfolio highlights
  • Inspide — Understand all the information in the real world and make it actionable
  • FYLA — At FYLA we create unique All-fiber Ultrafast pulsed lasers by Joining Singularity with Quality. Discover our multiphoton and two photon lasers!
  • 2Eyes Vision — 2EyesVision is a start-up (CSIC spin-off) specialized in the creation, development, and commercialization of novel ophthalmic technologies.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 11 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Reig Jofre VC Fund · Barcelona, Catalonia, Spain
Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.
Show more
Investment focus
  • Medical, Biopharma, Life Science
  • Funding Round
  • Spain
Portfolio highlights
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Global health sciences venture fund VC Fund · Vancouver, British Columbia, Canada
The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series C, Series A, Series B
  • United States, Canada, Spain
Portfolio highlights
  • EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
  • Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
  • CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
CRB Inverbío VC Fund · Madrid, Madrid, Spain
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Funding Round, Seed
  • Spain, Mexico
Portfolio highlights
  • Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
  • Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
  • Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Veg Capital VC Fund · Loughborough, Leicestershire, United Kingdom
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more
Investment focus
  • Food and Beverage, Biotechnology, Food Processing
  • Seed, Equity Crowdfunding, Pre-Seed
  • United Kingdom, Sweden, Brazil
Portfolio highlights
  • Super Vegan — Loja de chocolates veganos
  • SHICKEN Foods — Plant-based chicken manufacturer
  • The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
Grow Venture Partners VC Fund · Barcelona, Catalonia, Spain · 3 investments in the past 12 months
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more
Investment focus
  • Health Care, Artificial Intelligence, Biotechnology
  • Pre-Seed, Funding Round, Seed
  • Spain
Portfolio highlights
  • Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
  • Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
  • Qilimanjaro Quantum Tech — Discover the future of computing with Qilimanjaro's analog quantum solutions, tailored for large enterprises worldwide.
mVenturesBCN VC Fund · Barcelona, Catalonia, Spain
mVenturesBcn is a new player in the field of innovation.
Show more
Investment focus
  • Biopharma, Health Care, Life Science
  • Seed
  • Spain
Portfolio highlights
  • RheoDx — We provide a new way to measure the behavior of blood in motion. RHEO Dx can detect, with a sample of blood as small as a drop, minimum changes in rheological properties, that are an indicator of abnormalities in red blood cells morphology or rigidity. These abnormalities are associated with an enormous set of diseases and conditions, such as bloodcoagulation disorders , malignant homeopathies, malaria, hereditary anaemias, and any other disease related to blood cells rheology.
Catalan Institution for Research and Advanced Studies VC Fund
ICREA is a foundation supported by the Catalan Government for the advancement of research.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Spain
Portfolio highlights
Clave VC Fund · Pamplona, Navarra, Spain · 4 investments in the past 12 months
Clave is an investment management company.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Funding Round, Series A
  • Spain, Chile, Switzerland
Portfolio highlights
  • Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
  • Corify Care — CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to introduce in the market a novel medical device to non-invasively map cardiac arrhythmias in real time. This novel technology will improve the treatment in more than 10 million of atrial fibrillation patients only in Europe. Our non-invasiveelectro-anatomical mapping systems displays the activation patterns in each point of the heart without the need of invasive catheters, allowing the possibility to map all atrial fibrillation patients even during a regular visit to the cardiologist. CORIFY Care is located in Madrid, Spain, one of the most attractive places to work/live on the South of Europe.
  • Genbioma — Evidence-based microbiome company aims to leverage the central role of probiotics and the gut microbiota on the glycemic regulation. "Microbiota" "Premium probiotics" "Long-term glycemic regulation" "Prediabetes"
Grupo Ferrer Internacional VC Fund · Barcelona, Catalonia, Spain
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more
Investment focus
  • Biotechnology, Wellness, Biopharma
  • Series A, Funding Round
  • Spain
Portfolio highlights
  • Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
  • ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.
Alma Mundi Ventures VC Fund · Madrid, Madrid, Spain · 7 investments in the past 12 months
We back bold and purpose-driven founders.
Show more
Investment focus
  • Software, Insurance, InsurTech
  • Series A, Seed, Funding Round
  • Spain, United States, United Kingdom
Portfolio highlights
  • LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
  • Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
  • Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Innova-Tech Consulting VC Fund
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more
Investment focus
  • Solar, Energy, Medical
  • Series A, Seed, Series B
  • Canada, Spain
Portfolio highlights
  • SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
  • Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
  • Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
BCN PEPTIDES VC Fund · Mediona, Catalonia, Spain
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more
Investment focus
  • Medical, Biopharma, Life Science
  • Funding Round
  • Spain
Portfolio highlights
  • Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
CDTI VC Fund · Ventura, California, United States
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Debt Financing
  • Spain, United States, Mexico
Portfolio highlights
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Inveniam VC Fund · Barcelona, Catalonia, Spain
Supporting impact innovators to bring their breakthrough technologies to the market, for a healthier, safer and more sustainable world.
Show more
Investment focus
  • Biopharma, Health Care, Life Science
  • Seed, Funding Round
  • Spain
Portfolio highlights
  • AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
  • NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Spain by industry